Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

CMM Benzinsmed ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2016 2017/4 2017 2018/4 2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022e N/A 2023e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   17.1% 15.0% 5.4% 13.2% 15.8% 21.8% 20.3% 20.3%   Credit score (0-100)   12 15 43 18 12 4 5 4   Credit rating   BB BB BBB BB BB B B B   Credit limit (kDKK)   -0.0 -0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2016 2017/4 2017 2018/4 2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -5.0 -5.2 2,097 353 210 -32.4 0.0 0.0   EBITDA   -5.0 -5.2 647 -373 209 -32.4 0.0 0.0   EBIT   -5.0 -5.2 629 -424 195 -32.4 0.0 0.0   Pre-tax profit (PTP)   -5.6 -6.8 619.1 -435.8 189.9 -30.9 0.0 0.0   Net earnings   -5.6 -6.8 492.7 -409.6 217.7 -52.3 0.0 0.0   Pre-tax profit without non-rec. items   -5.6 -6.8 619 -436 190 -30.9 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2016 2017/4 2017 2018/4 2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022e N/A 2023e N/A Tangible assets total   0.0 0.0 114 14.8 0.0 0.0 0.0 0.0   Shareholders equity total   -18.0 -24.8 468 58.4 276 33.8 -46.2 -46.2   Interest-bearing liabilities   13.0 19.8 19.8 3.8 0.0 0.0 46.2 46.2   Balance sheet total (assets)   0.0 0.1 1,673 457 291 40.0 0.0 0.0   Net Debt   13.0 19.8 -1,134 -372 -16.0 0.0 46.2 46.2     See the entire balance sheet 1000.0 Volume  2016 2017/4 2017 2018/4 2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -5.0 -5.2 2,097 353 210 -32.4 0.0 0.0   Gross profit growth   0.0% -4.0% 0.0% -83.2% -40.6% 0.0% 0.0% 0.0%   Employees   0 0 6 1 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% -83.3% -100.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0 0 1,673 457 291 40 0 0   Balance sheet change%   0.0% 0.0% 2,743,262.3% -72.7% -36.4% -86.2% -100.0% 0.0%   Added value   -5.0 -5.2 646.6 -372.8 246.5 -32.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 97 -150 -28 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 -2.0 1.0 -1.0 1.0 -1.0 0.0 0.0   1000.0 Profitability  2016 2017/4 2017 2018/4 2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022e N/A 2023e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 100.0% 30.0% -120.1% 93.2% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -27.7% -12.1% 74.1% -39.8% 52.2% -18.1% 0.0% 0.0%   ROI %   -38.3% -15.8% 245.6% -152.8% 115.5% -19.3% 0.0% 0.0%   ROE %   0.0% -11,067.2% 210.6% -155.6% 130.2% -33.8% 0.0% 0.0%   1000.0 Solidity  2016 2017/4 2017 2018/4 2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022e N/A 2023e N/A Equity ratio %   -100.0% -99.8% 28.1% 12.8% 95.0% 84.4% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -260.8% -380.6% -175.3% 99.9% -7.7% 0.0% 0.0% 0.0%   Gearing %   -72.3% -80.1% 4.2% 6.5% 0.0% 0.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   9.9% 9.4% 51.9% 100.1% 282.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2016 2017/4 2017 2018/4 2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022e N/A 2023e N/A Quick Ratio   0.0 0.0 1.4 1.1 19.9 6.4 0.0 0.0   Current Ratio   0.0 0.0 1.4 1.1 19.9 6.4 0.0 0.0   Cash and cash equivalent   0.0 0.1 1,153.5 376.2 16.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2016 2017/4 2017 2018/4 2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022e N/A 2023e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -18.0 -24.8 480.3 43.6 276.1 33.8 -23.1 -23.1   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2016 2017/4 2017 2018/4 2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022e N/A 2023e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 108 -373 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 108 -373 0 0 0 0   EBIT / employee   0 0 105 -424 0 0 0 0   Net earnings / employee   0 0 82 -410 0 0 0 0